Ghorbanpour et al. created a placenta-on-chip to investigate the expression of the binding protein FK506 (FKBPL) and galectin 3 (Gal-3) that are associated with vascular dysfunction in preeclampsia and to study how the formation of the placental vascular network can vary during this pathology. Here, LGALS3 is linked to preeclampsia.